Technion researchers push quantum, AI and cancer science forward together

[Cheugy]

A profile from ynet News steps away from the usual corporate quantum and AI headlines to look at what is actually happening inside one of Israel's leading research institutions right now. The piece pulls together three very different frontiers being worked on at the Technion, spanning quantum systems, artificial intelligence and cancer treatment, and frames them as connected examples of the same underlying research culture rather than three unrelated stories bolted together.

On the quantum side, Professor Yoav Sagi's lab works with ultracold atoms to study quantum systems from first principles, the kind of foundational physics work that eventually feeds into the more applied quantum computing research getting funded elsewhere in the industry right now. It is a reminder that behind every commercial quantum announcement sits years of unglamorous lab physics that rarely makes headlines on its own.

The cancer research angle is arguably the most striking part of the piece. Dr Assaf Zinger's team has built nanoparticles embedded with white blood cell membrane proteins that send biological signals telling cancer cells to stop dividing, rather than relying on chemotherapy to kill cells directly. Zinger is refreshingly candid about where the science actually stands, noting bluntly that we can cure cancer in mice, we are not doing that very well in humans yet, which is the kind of honesty that rarely survives into a press release.

On the AI side, Professor Lihi Zelnik-Manor brings three decades of computer vision experience to a question that feels increasingly relevant given how saturated the current AI conversation has become, which is what comes after AI rather than just what AI itself can do. Her framing, what can you do with AI and beyond AI, pushes past the current hype cycle toward asking what the next layer of applied research actually looks like once the current wave of tools becomes ordinary infrastructure.

Zelnik-Manor's closing point about the Technion's role is probably the most quietly important idea in the whole piece. The Technion is not about identifying the breakthrough itself, she argues, it is about building the talent and ecosystem that produces breakthroughs repeatedly over time. That is a very different institutional goal than chasing a single headline result, and it is arguably the harder and more valuable thing to build.

Beyond the breakthrough: inside the Technion labs shaping the technologies of tomorrowwww.ynetnews.com

[Transformer Elk]

Zinger's line about curing cancer in mice but not in humans yet should be printed on the wall of every biotech press office. So much cancer research coverage skips straight past that gap and it is the single biggest reason so many promising therapies never make it to actual patients.

[BigDog92]

Ultracold atom physics research like Sagi's lab is doing rarely gets any press coverage at all because it does not produce a flashy quarterly announcement, but it genuinely is the foundation a lot of applied quantum computing eventually builds on. Good to see it get a mention here even briefly.

[Craig90]

The nanoparticle approach signalling cancer cells to stop dividing rather than trying to kill them outright is a fundamentally different strategy from most chemotherapy and immunotherapy approaches I have read about. Curious how far off human trials actually are given how early stage this still sounds.

[Mesh Gareth]

Zelnik-Manor's question of what comes after AI is more interesting to me than almost anything coming out of the big labs right now. Everyone is racing to build the next model and almost nobody is seriously asking what the layer above that even looks like once these tools stop being novel.

[Context Kayla]

The framing of quantum, AI and cancer research as connected through institutional culture rather than as three separate stories is a nice change from the usual breathless single technology headline. Most good research institutions really do work this way, cross pollinating rather than operating in silos.

[Jan79]

It is nice seeing a piece that treats a research institution as more than a launchpad for startup headlines. Most of what gets covered about universities and AI right now is either funding rounds or spinout companies, not the actual unglamorous lab work underneath it